Bela Denes

Chief Tech/Sci/R&D Officer presso LANTHEUS HOLDINGS, INC.

Health Technology

Consumer Services

Profilo

Bela S.
Denes is currently working as a Member at the American College of Surgeons and as a Vice President-Global Medical Affairs at Lantheus Holdings, Inc. In the past, he worked as a Lead-Global Medical Affairs at Amgen, Inc. and as a Chief Medical Officer & Vice President at Clarus Therapeutics, Inc.

Posizioni attive di Bela Denes

Società	Posizione	Inizio
LANTHEUS HOLDINGS, INC.	Chief Tech/Sci/R&D Officer	07/04/2021
American College of Surgeons	Corporate Officer/Principal	-

Tutte le posizioni attive di Bela Denes

Precedenti posizioni note di Bela Denes

Società	Posizione	Fine
AMGEN INC.	Chief Tech/Sci/R&D Officer	-
Clarus Therapeutics, Inc. Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL.	Chief Tech/Sci/R&D Officer	-

Vedi nel dettaglio l'esperienza di Bela Denes

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Bela Denes

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
AMGEN INC.	Health Technology
LANTHEUS HOLDINGS, INC.	Health Technology

Aziende private	1
Clarus Therapeutics, Inc. Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL.	Health Technology